• Welcome
• About
  • Decision Diagnostics Corp.
  • Board of Directors
  • Visit PharmaTech Solutions, Inc.
  • Careers
• Products
  • Diabetes Care
  • EMR Apps
• Investor Information
  • Financial Reports
  • Press Releases
  • Downloads

DECN Press Releases

March 2018

• Decision Diagnostics' Panacea Genprecis! Product Moves into Pre-Production, First Round Clinical Trials to Begin in the Next 30 Days (Jan 3)

• Decision Diagnostics' Fundamental Genchoice! Diabetic Test Strip Moves into Formal Managed Clinical Trials and Advanced Testing for Upcoming 510k Filing with U.S. FDA (Mar 13)

January 2018

• Decision Diagnostics Announces 2018 Business Focus Through the Introduction of New Products, Positive Conclusion to J&J Litigation, and Hybrid Private Label Business Model (Jan 3)

December 2017

• Decision Diagnostics Provides Additional Commentary About Its New GenAccord!(TM) Diabetic Test Strip (Dec 20)

• Decision Diagnostics Announces New GenAccord!(TM), Diabetic Test Strip with First Use of Its GenPrecis!(TM) Full Spread Electrode Technology (Dec 14)

November 2017

• Decision Diagnostics Corp. CEO Offers Primary Update on Legal Proceedings, Potential Outcomes, History, and Synopsis on Its Strategic Suit Against J&J (Nov 1)

October 2017

• Decision Diagnostics Corp. Further Discusses Its Panacea GenPrecis!(TM) Product Just Released into Advanced Development (Oct 18)

• Decision Diagnostics Announces Completion of Feasibility Testing for Their Inspired Genpresis!(TM) Precision Diabetes Glucose Testing System! (Oct 12)

• Decision Diagnostics Announces the Completion of Development and the Onset of Clinical Trials for Its Fundamental Genchoice!(TM) Diabetic Test Strip (Oct 10)

September 2017

• Patent Litigation Brought by Decision Diagnostics Subsidiaries against Johnson & Johnson/Lifescan Moves Toward Major Ruling (Sep 21)

• Decision Diagnostics Announces the Launch of Its Essential New Gensure!(TM) Diabetic Test Strip for Developing World Markets (Sep 13)

• Decision Diagnostics in Receipt of Revised Cash Offer from Proposed M&A Partner, Enhanced by 21% Over Previously Disclosed Proposals (Sep 7)

August 2017

• DECN Subsidiaries Plan Rebuttal Brief for Aug. 28th to Debunk J&J/Lifescan's Flawed Legal Reasoning and Factual Misrepresentations in Patent Case (Aug 24)

• Decision Diagnostics Board Reacts Positively to Above-Market Offer From Venture-Funded Company (Aug 2)

July 2017

• Decision Diagnostics Corp. Receives Surprise Acquisition Offer from Valued Venture Funded Company (Jul 13)

May 2017

• Decision Diagnostics Chairman and Director Robert Jagunich Retires from DECN Board of Directors (May 31)

• DECN Subsidiaries File Amended Complaint Against Jonhson & Johnson Alleging Infringement Under Authoritative Doctrine of Equivalents (May 4)

March 2017

• DECN Wins Opening Round in Innovatory Patent Infringement Suit Against Industry Goliath Johnson & Johnson (Mar 21)

• DECN Victorious as U.S. Supreme Court Rejects Johnson & Johnson Appeal Ending 65 Month Patent Infringement Litigation (Mar 1)

December 2016

• DECN Increases Manufacturing Capacity, Opens International Markets for Popular GenUltimate! (Dec 1)

November 2016

• DECN Opens International Markets for Popular Genultimate!, Increases Factory Capacity (Nov 30)

August 2016

• DECN Litigation Victory Against Johnson + Johnson, Launches Foothold in On-Line Retail Markets for Its Popular "Gen" Products (Aug 23)

July 2016

• Decision Diagnostics Ends Plans and Communications With Tauriga Sciences, Inc. Concerning Possible Reverse Merger Transaction (Jul 1)

June 2016

• Decision Diagnostics Emerges Victorious in End to Acrimonious Patent Litigation With Divisions of Johnson + Johnson (Jun 2)

May 2016

• Decision Diagnostics Nears Positive Ending of Its California Patent and Trademark Infringement Litigation With Divisions of Johnson + Johnson (May 12)

• Download Available: Federal Circuit Court Order Denying Appeal made by Lifescan and Johnson & Johnson and imposing mandate on May 17, 2016

• Download Available: Schedule Report for GenStrip50 TV Advertising (May 1)

April 2016

• Download Available: Schedule Report for GenStrip50 TV Advertising (Apr 25)

• Forbes Article: David-Goliath Fight Over Glucose Tests For Diabetics Hits Boiling Point (Apr 20)

• Decision Diagnostics Engages Retail Monster LLC to Procure Big Box Retailers for Company's GenUltimate Product (Apr 14)

March 2016

• Decision Diagnostics and Subsidiaries Elaborate on the Patent Infringement Lawsuit Against Johnson & Johnson and Two of Its Divisions (Mar 16)

• DECN Subsidiaries Sue Johnson & Johnson and Several Divisions for Patent Infringement (Mar 14)

February 2016

• Decision Diagnostics Conveys Opportunities and Potential Following Landmark Circuit Court Ruling Against Diabetes Testing Division of Johnson & Johnson (Feb 9)

January 2016

• DECN Assesses Its Recent Landmark Legal Victories Over Diabetes Division Of Johnson & Johnson (Jan 28)

• Decision Diagnostics Wins Federal Appeals Court Victory, Ruling Affirms J&J Division's Loss of US Patent No. 7,250,105 (Jan 21)

• We Win! United States Court of Appeals for the Federal Circuit - Opinion Filed for LifeScan Scotland, Ltd. v. Pharmatech Solutions, Inc. (Jan 20)

(Return to Top)

December 2015

• Download Available: United States Court of Appeals for the Federal Circuit - Oral Argument Recording for LifeScan Scotland, Ltd. v. Pharmatech Solutions, Inc. (Dec 18)

June 2015

• Decision Diagnostics Completes Investment in Korean R+D and Contract Manufacturing Partner (Jun 15)

• Decision Diagnostics Executes Broad Manufacturing and R+D Agreement With Korean Manufacturer (Jun 4)

May 2015

• Decision Diagnostics States Johnson & Johnson Division Offers Partial Surrender in Long Running Patent Battle (May 19)

• Decision Diagnostics Files Application for Uplisting to OTCMarkets OTCQX (May 12)

April 2015

• Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case (Apr 21)

• U.S. Solicitor General Intervenes Against Johnson & Johnson in DECN's Long Running Patent Battle Over GenStrip 50 (Apr 14)

March 2015

• Johnson & Johnson Division Attempts Final Appeal in Effort to Overturn Multiple USPTO Decisions Issued in DECN's Favor (Mar 31)

• Decision Diagnostics Rejects Settlement Offers From J&J/Lifescan, Company's Prosecutions of Court Bond and Anti-Trust Actions Now Move On (Mar 4)

January 2015

• Updated TV Commercial Fulfillment (Jan 20)

• DECN Plans New Legal Challenge After LifeScan (J&J) Admits to Using Sworn Testimony From Expert With Falsified Credentials (Jan 14)

(Return to Top)

December 2014

• DECN Initiates End Game Strategy For Litigation With Division Of Johnson & Johnson (Dec 3)

November 2014

• DECN's Subsidiary Initiates First In Industry Social Media Marketing Campaign For Genstrip50 (Nov 5)

August 2014

• David Defeats Goliath (Again), DECN and Pharma Tech Solutions Awarded Victory Over Johnson & Johnson Lifescan in USPTO Final Ruling (Aug 11)

• David Beats Goliath in Patent Rematch (Aug 7)

June 2014

• DECN's Pharma Tech Subsidiary Places Significant Order for 50,000 Units of Genstrip 50 for Immediate Delivery to Select U.S. and International Distributors (Jun 3)

May 2014

• Decision Diagnostics Corp. Subsidiary Pharma Tech Enters International Markets With Conformité Européenne (CE) Mark Submission (May 29)

• GenStrip Opportunity Expands Under Full Control of DECN's PharmaTech Division (May 1)

April 2014

• Decision Diagnostics Responds to Shasta Technologies FDA Safety Warning Letter (Apr 30)

• Decision Diagnostics Subsidiary Acquires GenStrip (Apr 16)

March 2014

• Decision Diagnostics Announces Posting and Airing of Its New GenStrip Commercial Titled "Monolith"(Mar 31)

• Decision Diagnostics Announces Engagement of Mark Krakauer to Head Up Genstrip Private Label Sales Efforts (Mar 11)

• TV Commercials Fulfillment #3 (Mar 4)

February 2014

• TV Commercials Fulfillment #2 (Feb 26)

• Decision Diagnostics Announces Agreement for Funding of Its Prosecution of Anti-Trust and False Advertising Suits Against Division of Johnson & Johnson (Feb 18)

• TV Commercials Fulfillment #1 (Feb 15)

• Decision Diagnostics Announces Agreement for the Funding of Its Prosecution of Anti-Trust and False Advertising Suits Against Division of Johnson & Johnson (Feb 14)

January 2014

• Decision Diagnostics Announces Posting and Airing of Its New GenStrip Commercial Titled "A Winter Patchwork" (Jan 15)

(Return to Top)

December 2013

• Decision Diagnostics Closes $12.5 Million (Non-Dilutive) Credit Facility With Division of Platinum Credit Management (Dec 19)

• Decision Diagnostics Starts its Turnaround (Dec 17)

• Decision Diagnostics Receives Mandate From U.S. Court of Appeals for the Federal Circuit in the Long Running Dispute With J&J Division (Dec 17)

• Mandate from Federal Appeals Court (.pdf) (Dec 11)

• Decision Diagnostics' Board Votes to Uplist to OTC QX (Dec 10)

November 2013

• Decision Diagnostics Takes Victory In Major Case Ruling (Nov 11)

• Diabetes: J&J loses a round in glucose testing battle with Shasta (Nov 7)

• Decision Diagnostics On Track For Growth And Increased Revenues (Nov 7)

• DECN And Pharma Tech Solutions Receive Anticipated Ruling From The U.S. Federal Circuit Court Of Appeals, Reversing A Ruling By Lower Court Judge (Nov 5)

• DECN Wins Only Case That Matters in Federal Circuit Court (.pdf) (Nov 4)

October 2013

• Well Ahead Of Schedule, Decision Diagnostic's Pharma Tech Division Completes First Major Shipments Of Its Popular Genstrip Test Strip (Oct 31)

• Decision Diagnostics Receives Signed Term Sheet Agreement For $12.5 Million Revolving Credit Facility Which Will Complete DECN’s GenStrip Roll-Out Plan (Oct 29)

• Decision Diagnostics Could Be The New Vringo (Oct 24)

• Recognized Healthcare And Financial Publications Acknowledge Decision Diagnostics’ GenStrip Market Potential (Oct 22)

• DECN Set To Climb As GenStrip Enters Blood Glucose Monitoring Market With First Shipments (Oct 22)

• Decision Diagnostic Blood Glucose Test Strip Technology Enters Market with Genstrip (Oct 22)

• Court Ruling for Decision Diagnostics Order Staying Proceedings (.pdf) (Oct 9)

• Decision Diagnostics' Pharma Tech Division Schedules Shipments For Its Popular GenStrip Test Strip (Oct 3)

• Decision Diagnostics' Pharma Tech Division Schedules Large Order Shipments for Its Popular GenStrip Test Strip (Oct 1)

September 2013

• David And Goliath Case Offers A Surprising Opportunity (Sep 26)

• J&J feels Decision Diagnostics' sting in glucose strip patent fight (Sep 12)

• J&J's Blood Sugar Testing Patent Spat Turns Sour (Sep 12)

• J&J Seeks Court Aid To Protect Its Glucose Monitoring Test (Sep 11)

• Decision Diagnostics Corp. Announces Completion and Airing of Its New Genstrip Video Titled "A Patchwork of Life" (Sep 10)

• Decision Diagnostic's GenStrip Could Change the Blood Glucose Market (Sep 1)

August 2013

• Court's Ruling on PharmaTech's Motion for Contempt (Aug 28)

• GenStrip™ and USPTO Ruling (Aug 15)

• Decision Diagnostics Subsidiary Makes Move and Sues Two Johnson and Johnson Divisions for False Advertising in Ongoing Battle (Aug 1)

May 2013

• DECN Steps Into Role of White Knight by Offering Strategic Version of GenStrip™ Exclusively for Medicare Competitive Bidding Program (May 29)

• Decision Diagnostics Corp. is saddened to announce the sudden passing of our long-time friend and Computer and Information Systems Manager, Mr. Alan B Binder (May 10)

April 2013

• Decision Diagnostics Corp. and Its Subsidary PharmaTech Solutions Seek to End Pharma Giant's Alleged Restraint of Trade Tactics (Apr 5)

• Decision Diagnostics Corp. and Its Subsidiary PharmaTech Solutions, Inc. Sue Johnson & Johnson Division LifeScan, Inc. and LifeScan Scotland Ltd. for Antitrust Violations (Apr 4)

March 2013

• J&J Faces Potentially Disrupting Competition In Its Lucrative Glucose Monitoring Business From Tiny Diagnostics Outfit (Mar 11)

January 2013

• FDA Review - Decision Summary (Jan 2)

• FDA 510(k) Premarket Notification (Jan 2)

(Return to Top)

December 2012

• FDA 510(K) Clearance Letter (Dec 5)

• Opportunity and Market for Decision Diagnostics (OTCBB:DECN) Shasta GenStrip®; at home diagnostic for testing blood glucose (Dec 4)

November 2012

• Medical Technology Stock Q&A with Decision Diagnostics (Nov 28)

• Medical Technology Stock Decision Diagnostics Lead Product Shasta Genstrip Positions for at-home testing of Blood Glucose Market (Nov 21)

• Decision Diagnostics Set to Become Force in at-home testing of blood glucose, estimated $22.5 Billion Worldwide (Nov 16)

January 2012

• Decision Diagnostics Corp. is saddened to announce the passing of our friend and financial guidance advisor, Mr. William N. Walling, Jr. (Jan 18)

• Medical IT and Diagnostic Product Company Decision Diagnostics Announces Patent Enforcement Strategy for Their Smart Phone Based EMR Technology (Jan 11)

(Return to Top)

December 2011

• Decision Diagnostic Corp. Clarifies 10% Stock Dividend, Announces Patent Enforcement Strategy (Dec 27)

• Decision Diagnostic Corp. (Formerly InstaCare) Announces 10% Stock Dividend (Dec 6)

• Instacare Changes Name to Decision Diagnostics Corp.; Will Apply for Nasdaq Bx Exchange Listing (Dec 1)

May 2011

• Instacare Corp. Board of Directors Considers Recent Merger Proposal Inadequate (May 11)

• InstaCare Corp. Receives Second Confidential Merger Offer From NASDAQ Traded Company (May 9)

April 2011

• InstaCare Subsidiary Signs New Agreement for Expanded Management and Sales of Shasta Genstrip Into the $20 Billion Worldwide Diabetes Testing Market (Apr 18)

March 2011

•  Download Hudson Securities - OTC Bulletin Board (.pdf) (Mar 11)

• MD@Detail coming soon!

• InstaCare Announces Ready for Market MD@Detail Mobile Health Media System for Pharmaceutical e-Detailing (Mar 10)

• InstaCare Extends MD@Hand & MD@Work Mobile EMR/EHR Technology to Smart Pad Systems (Mar 3)

• InstaCare Announces Receipt of Technology and Patent Value Analysis Penned by Joseph Wolf, Ph.D and William Walling, CFA (Mar 2)

February 2011

• InstaCare Files Full Utility Patent for MD@Hand & MD@Work Technologies (Feb 28)

(Return to Top)

June 2010

• InstaCare Subsidiary Inks 5-Year Exclusive Pact for Distribution of Proprietary Diabetes Test Strip Into $9.8 Billion Testing Market (Jun 24)

• InstaCare Retains Martin E. Janis & Company, Inc. to Launch Nationwide Comprehensive IR/PR Program(Jun 3)

March 2010

• Instacare Corp. Files Patent Application for its MD@Hand Cell Phone Centric Technologies (Mar 2)

February 2010

• instaCare Corp. Announces Launch of Infomercial Marketing Strategy (Feb 2)

January 2010

• Download Available: Instacare Corp. States Conference Call on January 27 is a Success - Click here to download Conference Call (.mp3) (Jan 27)
  

• Instacare Corp. Announces Details of Conference Call on January 27 (Jan 25)

• instaCare Corp. Finalizes MD@Hand Parallel Marketing Strategy (Jan 25)

• DownLoad Available: Download Chairman's Letter to Stockholders(.pdf) (Jan 20)

• instaCare Corp. Elects William Lyons to Its Board of Directors (Jan 14)

• instaCare Corp. Finalizes MD@Hand Parallel Marketing Strategy (Jan 12)

• Instacare Corp. to Host Shareholder Conference Call on January 27, 2010 to Discuss Recent Events (Jan 4)

(Return to Top)

December 2009

• Instacare Corp. Board of Directors Sets Growth Plans for 2010 (Dec 17)

• Instacare Moves to Secure Patents for Its Newest Technologies, Announces Parallel Strategies for Its Revolutionary MD@Hand Cell-Centric Products (Dec 3)

November 2009

• instaCare in Renewal and Increase of its $2 Million Monthly Revolving Credit Facility With Centurion Credit Resources, LLC (Nov 30)

• ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes (Nov 23)

• instaCare Corp. Continues Turnaround, Reports 58% Revenues Increase for First Three Quarters (Nov 18)

(Return to Top)

May 2008

• InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 (May 21)

September 2007

• InstaCare Corp. Reviewing M&A Plans (Sep 26)

April 2007

• Instacare Corp. Announces Expanded Product Lines, Group Vendor Agreements and Enhanced Customer Base (Apr 04)

July 2006

• InstaCare Corp. in Contract Deliberations With Mexican Government Health Institute ISSSTE for E-Health Implementation Pact (Jul 20)

• InstaCare Receives Enhanced Targets and Rating From Wasserman Morris in Latest Research Report (Jul 17)

May 2006

• instaCare Corp. to Hold Conference Call May 25, 2006 (May 23)

September 2005

• instaCare Corp. Comments on Recent Significant News Concerning the Efficacy of Cost Saving Wireless Technologies in Healthcare (Sep 13)

(Return to Top)

Contact Us

Decision Diagnostics
Ph: 805-446-1973
Fax: 805-446-1983
Email: info@decisiondiagnostics.com

Our main office is on
2660 Townsgate Rd, Suite 300,
Westlake Village, CA